GRESX | VGSLX | GRESX / VGSLX | |
Total Expense Ratio | 1.35 | 0.13 | 1,038% |
Annual Report Gross Expense Ratio | 1.71 | 0.13 | 1,315% |
Fund Existence | 27 years | 24 years | - |
Gain YTD | 0.697 | 1.847 | 38% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 81.2M | 63.6B | 0% |
Annual Yield % from dividends | 1.60 | 4.06 | 39% |
Returns for 1 year | 4.48 | 11.36 | 39% |
Returns for 3 years | 7.41 | 16.46 | 45% |
Returns for 5 years | 9.08 | 34.69 | 26% |
Returns for 10 years | -30.17 | 62.69 | -48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JIAFX | 9.27 | -0.04 | -0.43% |
JHancock Multi-Asset High Income A | |||
CIMFX | 26.18 | -0.14 | -0.53% |
American Funds Income Fund of Amer 529F1 | |||
FPHAX | 25.67 | -0.22 | -0.85% |
Fidelity Select Pharmaceuticals Port | |||
GSGCX | 43.85 | -0.40 | -0.90% |
Goldman Sachs Equity Income C | |||
BSFIX | 31.86 | -0.58 | -1.79% |
Baron Small Cap Instl |